1-20 of 72
Keywords: Aspirin
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Cerebrovasc Dis 1–9.
Published Online: 18 November 2023
... or aspirin, and 781 (32.4%) received DAPT. Recurrent stroke occurred in 108 (6.6%) patients of the mono-antiplatelet group and 40 (5.1%) patients of the DAPT group (adjusted hazard ratio [aHR] 0.73, 95% confidential interval [CI] 0.47–1.13, p = 0.16) at 3 months, and the rate of stroke recurrence was 10.7...
Journal Articles
Cerebrovasc Dis (2020) 49 (3): 237–243.
Published Online: 05 May 2020
... demonstrated the superiority of early dual antiplatelet therapy (DAPT), using aspirin (ASA) plus Clo, in comparison to ASA alone following the occurrence of acute minor cerebral infarction or transient ischemic attack. However, limitations to these trials exist that may not have been adequately explored...
Journal Articles
Cerebrovasc Dis (2018) 45 (3-4): 180–186.
Published Online: 03 April 2018
... study, we examined the effect of most widely used antiplatelet drugs, aspirin and cilostazol, on aneurysm rupture prevention using a mouse intracranial aneurysm model. Materials and Methods: Intracranial aneurysms were induced by a combination of deoxycorticosterone acetate-salt and a single injection...
Journal Articles
Journal Articles
Cerebrovasc Dis (2015) 39 (5-6): 332–342.
Published Online: 07 May 2015
...Robert M. Starke; Nohra Chalouhi; Dale Ding; David M. Hasan Background: Inflammation is a key element behind the pathophysiology of cerebral aneurysm formation and rupture. Aspirin is a potent inhibitor of cyclooxygenase-2 (COX), which plays a critical role in the expression of immune modulators...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Cerebrovasc Dis (2010) 30 (4): 330–339.
Published Online: 05 August 2010
... ischaemia occurs in the same way as leg ischaemia). By implication, similar errors may well be hidden in present ideas about stroke. Probable or possible examples are the idées reçues that 30 mg of aspirin is less efficacious in the secondary prevention of stroke than 100 mg, that vasospasm is the cause...
Journal Articles
Cerebrovasc Dis (1995) 5 (4): 308–309.
Published Online: 26 May 2010
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Aspirin Stroke prevention Short Report Ccrebrovasc Dis 1995;5:308-309 M.G. Hennerici Neurologische Klinik der Universität zu Heidelberg, Klinikum Mannheim, Mannheim...
Journal Articles
Cerebrovasc Dis (1995) 5 (2): 156–157.
Published Online: 26 May 2010
...J.P. Mohr The Warfarin-Antiplatelet Recurrent Stroke Study is a multicenter, randomized, double-blind study comparing warfarin against aspirin in the prevention of recurrent stroke. No patient takes two active medications or two placebos. Warfarin is used in 2 mg doses sufficient to keep...
Journal Articles
Cerebrovasc Dis (2001) 11 (Suppl. 1): 49–54.
Published Online: 01 April 2010
.... Aspirin has been shown to offer a modest benefit when studied in patients treated within 48 h of stroke onset. Ancrod is an antithrombotic agent that acts by reducing circulating fibrinogen levels. Patients treated within 3 h of stroke symptom onset had a better functional outcome at 90 days compared...
Journal Articles
Cerebrovasc Dis (2001) 11 (Suppl. 1): 96–99.
Published Online: 01 April 2010
...Natan M. Bornstein Antiplatelets are the pivotal drugs in preventing recurrent stroke or other major vascular events in patients who have undergone TIA or stroke. Aspirin is the most widely used, although its effect is very modest (relative risk reduction 20%), and most physicians use between 100...
Journal Articles
Cerebrovasc Dis (2001) 11 (Suppl. 1): 100–104.
Published Online: 01 April 2010
... choice. In the case of a contraindication to such treatment, aspirin and ibuprofen are safe, but less effective alternatives. In patients with cerebral ischaemia of presumed arterial origin, anticoagulation with an achieved intensity of 3.0–4.5 proved not to be safe. Results from trials with more...
Journal Articles
Journal Articles